Abstract:Glioblastoma (GBM) is an aggressive tumor of the central nervous system categorized by the World Health Organization as a Grade 4 astrocytoma. Despite treatment with surgical resection, adjuvant chemotherapy, and radiation therapy, outcomes remain poor, with a median survival of only 14-16 months. Although tumor regression is often observed initially after treatment, long-term recurrence or progression invariably occurs. Tumor growth, invasion, and recurrence is mediated by a unique population of glioblastoma stem cells (GSCs). Their high mutation rate and dysregulated transcriptional landscape augment their resistance to conventional chemotherapy and radiation therapy, explaining the poor outcomes observed in patients. Consequently, GSCs have emerged as targets of interest in new treatment paradigms. Here, we review the unique properties of GSCs, including their interactions with the hypoxic microenvironment that drives their proliferation. We discuss vital signaling pathways in GSCs that mediate stemness, self-renewal, proliferation, and invasion, including the Notch, epidermal growth factor receptor, phosphatidylinositol 3-kinase/Akt, sonic hedgehog, transforming growth factor beta, Wnt, signal transducer and activator of transcription 3, and inhibitors of differentiation pathways. We also review epigenomic changes in GSCs that influence their transcriptional state, including DNA methylation, histone methylation and acetylation, and miRNA expression. The constituent molecular components of the signaling pathways and epigenomic regulators represent potential sites for targeted therapy, and representative examples of inhibitory molecules and pharmaceuticals are discussed. Continued investigation into the molecular pathways of GSCs and candidate therapeutics is needed to discover new effective treatments for GBM and improve survival.

Cancer stem cells in glioblastoma

Cancer Stem Cells: Significance in Origin, Pathogenesis and Treatment of Glioblastoma

Cancer Stem Cells in Glioblastoma—molecular Signaling and Therapeutic Targeting

Seeing is Believing: Are Cancer Stem Cells the Loch Ness Monster of Tumor Biology?

Potential Therapeutic Implications of Cancer Stem Cells in Glioblastoma

Glioblastoma stem cells: lessons from the tumor hierarchy in a lethal cancer

Glioblastoma Stem Cells—Useful Tools in the Battle against Cancer

Molecular Pathways and Genomic Landscape of Glioblastoma Stem Cells: Opportunities for Targeted Therapy

Glioblastoma Stem-Like Cells: Characteristics, Microenvironment, and Therapy.

Cancer stem cell hypothesis 2.0 in glioblastoma: Where are we now and where are we going?

Targeting role of glioma stem cells for glioblastoma multiforme.

Common Denominators of Self-renewal and Malignancy in Neural Stem Cells and Glioma

Brain tumors: Cancer stem-like cells interact with tumor microenvironment

KR158 Spheres Harboring Slow-Cycling Cells Recapitulate High-Grade Glioma Features in an Immunocompetent System

Elevated Invasive Potential of Glioblastoma Stem Cells.

Hit 'em Where They Live: Targeting the Cancer Stem Cell Niche

KR158 spheres harboring slow-cycling cells recapitulate GBM features in an immunocompetent system

The Three-Layer Concentric Model of Glioblastoma: Cancer Stem Cells, Microenvironmental Regulation, and Therapeutic Implications

Glioblastoma stem cells show transcriptionally correlated spatial organization

The heterogeneous cellular states of glioblastoma stem cells revealed by single cell analysis

Targeting Glioblastoma Stem Cells: A Review on Biomarkers, Signal Pathways and Targeted Therapy